idelalisib
(IFSDAJWBUCMOAH-HNNXBMFYSA-N)
Structure
- SMILES
- CC[C@@H](c1nc2cccc(c2c(=O)n1c1ccccc1)F)Nc1ncnc2c1[nH]cn2
- Type(s)
- Approved
- ATC code(s)
- L01XX47
- Molecular Formula:
- C22H18FN7O
- Molecular Weight:
- 415.423
- Log P:
- 3.8273
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 2
- TPSA:
- 101.38
- CAS Number(s):
- 870281-82-6; 1146702-54-6; 1453810-72-4
Synonym(s)
1.
idelalisib
2.
CAL 101
3.
CAL-101
4.
CAL101
5.
GS-1101
6.
Zydelig
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Disease Progression | FAERS: 585 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 2 | Pneumonia | FAERS: 138 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 3 | Drug ineffective | FAERS: 117 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 4 | Fatigue | FAERS: 93 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 5 | Dehydration | FAERS: 84 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Malaise | FAERS: 75 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 7 | Vomiting | FAERS: 66 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 8 | Pneumonitis | FAERS: 64 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 9 | Asthenia | FAERS: 62 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 10 | Infection | FAERS: 60 | US FAERS | |
| 11 | Colitis | FAERS: 57 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Nausea | FAERS: 55 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Weight decreased | FAERS: 52 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 14 | Sepsis | FAERS: 41 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 15 | Chills | FAERS: 37 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 16 | Neutropenia | FAERS: 36 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | White blood cell count decreased | FAERS: 34 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 18 | Lymphoma | FAERS: 33 | 23676220 | CTD US FAERS |
| 19 | Atrial Fibrillation | FAERS: 32 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Lymphadenopathy | FAERS: 32 | US FAERS | |
| 21 | Unevaluable event | FAERS: 31 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 22 | Pain | FAERS: 30 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Headache | FAERS: 28 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 24 | Dizziness | FAERS: 26 | US FAERS | |
| 25 | Peripheral swelling | FAERS: 26 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 26 | Abdominal Pain | FAERS: 25 | US FAERS | |
| 27 | Drug dose omission | FAERS: 23 | US FAERS | |
| 28 | Cerebrovascular accident | FAERS: 22 | US FAERS | |
| 29 | Constipation | FAERS: 22 | US FAERS | |
| 30 | Urinary tract infection | FAERS: 22 | US FAERS | |
| 31 | Back Pain | FAERS: 21 | US FAERS | |
| 32 | Influenza | FAERS: 21 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 33 | Acute kidney injury | FAERS: 19 | US FAERS | |
| 34 | Clostridium difficile infection | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Respiratory Failure | FAERS: 19 | US FAERS | |
| 36 | Pancytopenia | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 37 | Transaminases increased | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Pruritus | FAERS: 16 | US FAERS | |
| 39 | Arthralgia | FAERS: 15 | US FAERS | |
| 40 | Bronchitis | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 41 | Electrolyte imbalance | FAERS: 15 | US FAERS | |
| 42 | Product use issue | FAERS: 15 | US FAERS | |
| 43 | Stomatitis | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 44 | Feeling abnormal | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Thrombocytopenia | FAERS: 14 | US FAERS | |
| 46 | Thrombosis | FAERS: 14 | US FAERS | |
| 47 | Nasopharyngitis | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Richter's syndrome | FAERS: 13 | US FAERS | |
| 49 | Febrile Neutropenia | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 50 | Hypotension | FAERS: 12 | US FAERS | |
| 51 | Night sweats | FAERS: 12 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 52 | Septic Shock | FAERS: 12 | US FAERS | |
| 53 | Squamous cell carcinoma | FAERS: 12 | US FAERS | |
| 54 | Blood count abnormal | FAERS: 11 | US FAERS | |
| 55 | Cataract | FAERS: 11 | US FAERS | |
| 56 | Chest Pain | FAERS: 11 | US FAERS | |
| 57 | Intentional product use issue | FAERS: 11 | US FAERS | |
| 58 | Hypersensitivity | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 59 | Pulmonary Embolism | FAERS: 10 | US FAERS | |
| 60 | Toxicity to various agents | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 61 | Tremor | FAERS: 10 | US FAERS | |
| 62 | Abdominal discomfort | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 63 | Cellulitis | FAERS: 9 | US FAERS | |
| 64 | Dementia | FAERS: 9 | US FAERS | |
| 65 | Diverticulitis | FAERS: 9 | US FAERS | |
| 66 | Intentional dose omission | FAERS: 9 | US FAERS | |
| 67 | Myocardial Infarction | FAERS: 9 | US FAERS | |
| 68 | Sinusitis | FAERS: 9 | US FAERS | |
| 69 | Stem cell transplant | FAERS: 9 | US FAERS | |
| 70 | Alopecia | FAERS: 8 | US FAERS | |
| 71 | Device related infection | FAERS: 8 | US FAERS | |
| 72 | General physical health deterioration | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 73 | Haematotoxicity | FAERS: 8 | US FAERS | |
| 74 | Intestinal Obstruction | FAERS: 8 | US FAERS | |
| 75 | Memory impairment | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 76 | Myalgia | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 77 | Skin lesion | FAERS: 8 | US FAERS | |
| 78 | Alanine Aminotransferase Increased | FAERS: 7 | US FAERS | |
| 79 | Blood creatinine increased | FAERS: 7 | US FAERS | |
| 80 | Cytopenia | FAERS: 7 | US FAERS | |
| 81 | Deep Vein Thrombosis | FAERS: 7 | US FAERS | |
| 82 | Epistaxis | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 83 | Erythema | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 84 | Neck Pain | FAERS: 7 | US FAERS | |
| 85 | Neutrophil count decreased | FAERS: 7 | US FAERS | |
| 86 | Product dose omission | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 87 | Productive Cough | FAERS: 7 | US FAERS | |
| 88 | Rash erythematous | FAERS: 7 | US FAERS | |
| 89 | Visual Impairment | FAERS: 7 | US FAERS | |
| 90 | Acute respiratory failure | FAERS: 6 | US FAERS | |
| 91 | Arthritis | FAERS: 6 | US FAERS | |
| 92 | Basal cell carcinoma | FAERS: 6 | US FAERS | |
| 93 | Clostridium difficile colitis | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 94 | Diabetes Mellitus | FAERS: 6 | US FAERS | |
| 95 | Diffuse Large B-Cell Lymphoma | FAERS: 6 | US FAERS | |
| 96 | Gastric infection | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 97 | Hypophagia | FAERS: 6 | US FAERS | |
| 98 | Hypoxia | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 99 | Lower respiratory tract infection | FAERS: 6 | US FAERS | |
| 100 | MYELODYSPLASTIC SYNDROME | FAERS: 6 | US FAERS | |
| 101 | Oral pain | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 102 | Pancreatitis | FAERS: 6 | US FAERS | |
| 103 | Respiratory distress | FAERS: 6 | US FAERS | |
| 104 | Skin reaction | FAERS: 6 | US FAERS | |
| 105 | Squamous cell carcinoma of skin | FAERS: 6 | US FAERS | |
| 106 | Terminal state | FAERS: 6 | US FAERS | |
| 107 | Therapy cessation | FAERS: 6 | US FAERS | |
| 108 | Urticaria | FAERS: 6 | US FAERS | |
| 109 | Abdominal mass | FAERS: 5 | US FAERS | |
| 110 | Anxiety | FAERS: 5 | US FAERS | |
| 111 | B-cell lymphoma recurrent | FAERS: 5 | US FAERS | |
| 112 | Blood glucose increased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 113 | Blood lactate dehydrogenase increased | FAERS: 5 | US FAERS | |
| 114 | Blood potassium decreased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 115 | Cystitis | FAERS: 5 | US FAERS | |
| 116 | Dry skin | FAERS: 5 | US FAERS | |
| 117 | Dyspepsia | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 118 | Hepatotoxicity | FAERS: 5 | US FAERS | |
| 119 | Hernia | FAERS: 5 | US FAERS | |
| 120 | Hyperpyrexia | FAERS: 5 | US FAERS | |
| 121 | Infectious colitis | FAERS: 5 | US FAERS | |
| 122 | Joint swelling | FAERS: 5 | US FAERS | |
| 123 | Malignant neoplasm progression | FAERS: 5 | US FAERS | |
| 124 | Osteoporosis | FAERS: 5 | US FAERS | |
| 125 | Pericardial effusion | FAERS: 5 | US FAERS | |
| 126 | Pulmonary Fibrosis | FAERS: 5 | US FAERS | |
| 127 | Pulmonary thrombosis | FAERS: 5 | US FAERS | |
| 128 | Splenomegaly | FAERS: 5 | US FAERS | |
| 129 | Swelling | FAERS: 5 | US FAERS | |
| 130 | Wheezing | FAERS: 5 | US FAERS | |
| 131 | White blood cell count abnormal | FAERS: 5 | US FAERS | |
| 132 | Abasia | FAERS: 4 | US FAERS | |
| 133 | Aphasia | FAERS: 4 | US FAERS | |
| 134 | Aspartate Aminotransferase Increased | FAERS: 4 | US FAERS | |
| 135 | Blood sodium decreased | FAERS: 4 | US FAERS | |
| 136 | Blood urine present | FAERS: 4 | US FAERS | |
| 137 | Chemotherapy | FAERS: 4 | US FAERS | |
| 138 | Choking | FAERS: 4 | US FAERS | |
| 139 | Disability | FAERS: 4 | US FAERS | |
| 140 | Dysgeusia | FAERS: 4 | US FAERS | |
| 141 | Escherichia infection | FAERS: 4 | US FAERS | |
| 142 | Failure to Thrive | FAERS: 4 | US FAERS | |
| 143 | Flatulence | FAERS: 4 | US FAERS | |
| 144 | Gastrointestinal inflammation | FAERS: 4 | US FAERS | |
| 145 | Hospice Care | FAERS: 4 | US FAERS | |
| 146 | Incoherent | FAERS: 4 | US FAERS | |
| 147 | Intestinal Perforation | FAERS: 4 | US FAERS | |
| 148 | Leukopenia | FAERS: 4 | US FAERS | |
| 149 | Lower respiratory tract inflammation | FAERS: 4 | US FAERS | |
| 150 | Lymphocytosis | FAERS: 4 | US FAERS | |
| 151 | Mantle cell lymphoma | FAERS: 4 | US FAERS | |
| 152 | Nephrolithiasis | FAERS: 4 | US FAERS | |
| 153 | Pulmonary congestion | FAERS: 4 | US FAERS | |
| 154 | Secretion discharge | FAERS: 4 | US FAERS | |
| 155 | Somnolence | FAERS: 4 | US FAERS | |
| 156 | Syncope | FAERS: 4 | US FAERS | |
| 157 | Therapeutic response unexpected | FAERS: 4 | US FAERS | |
| 158 | Transplant | FAERS: 4 | US FAERS | |
| 159 | jaundice | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 160 | treatment failure | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 161 | Accidental overdose | FAERS: 3 | US FAERS | |
| 162 | Acute myocardial infarction | FAERS: 3 | US FAERS | |
| 163 | Angina Pectoris | FAERS: 3 | US FAERS | |
| 164 | Ascites | FAERS: 3 | US FAERS | |
| 165 | Atypical pneumonia | FAERS: 3 | US FAERS | |
| 166 | Autoimmune colitis | FAERS: 3 | US FAERS | |
| 167 | Blood magnesium decreased | FAERS: 3 | US FAERS | |
| 168 | Cardiac Arrest | FAERS: 3 | US FAERS | |
| 169 | Cheilitis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 170 | Chest discomfort | FAERS: 3 | US FAERS | |
| 171 | Chromaturia | FAERS: 3 | US FAERS | |
| 172 | Cold sweat | FAERS: 3 | US FAERS | |
| 173 | Disease recurrence | FAERS: 3 | US FAERS | |
| 174 | Disorientation | FAERS: 3 | US FAERS | |
| 175 | Dysphonia | FAERS: 3 | US FAERS | |
| 176 | Eczema | FAERS: 3 | US FAERS | |
| 177 | Endocarditis | FAERS: 3 | US FAERS | |
| 178 | Enteritis | FAERS: 3 | US FAERS | |
| 179 | Immunosuppression | FAERS: 3 | US FAERS | |
| 180 | Intentional product misuse | FAERS: 3 | US FAERS | |
| 181 | Lip swelling | FAERS: 3 | US FAERS | |
| 182 | Lymphoma transformation | FAERS: 3 | US FAERS | |
| 183 | Mental status changes | FAERS: 3 | US FAERS | |
| 184 | Oropharyngeal pain | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 185 | Osteomyelitis | FAERS: 3 | US FAERS | |
| 186 | Pelvic Pain | FAERS: 3 | US FAERS | |
| 187 | Post procedural infection | FAERS: 3 | US FAERS | |
| 188 | Product storage error | FAERS: 3 | US FAERS | |
| 189 | Psoriasis | FAERS: 3 | US FAERS | |
| 190 | Renal pain | FAERS: 3 | US FAERS | |
| 191 | Rhinovirus infection | FAERS: 3 | US FAERS | |
| 192 | Stevens-Johnson Syndrome | FAERS: 3 | US FAERS | |
| 193 | Stress | FAERS: 3 | US FAERS | |
| 194 | Therapy change | FAERS: 3 | US FAERS | |
| 195 | Therapy non-responder | FAERS: 3 | US FAERS | |
| 196 | Ulcer | FAERS: 3 | US FAERS | |
| 197 | Upper-airway cough syndrome | FAERS: 3 | US FAERS | |
| 198 | Abdominal cavity drainage | FAERS: 2 | US FAERS | |
| 199 | Abdominal tenderness | FAERS: 2 | US FAERS | |
| 200 | Ageusia | FAERS: 2 | US FAERS | |
| 201 | Agranulocytosis | FAERS: 2 | US FAERS | |
| 202 | Amnesia | FAERS: 2 | US FAERS | |
| 203 | Ankle Fracture | FAERS: 2 | US FAERS | |
| 204 | Anuria | FAERS: 2 | US FAERS | |
| 205 | Arthropod bite | FAERS: 2 | US FAERS | |
| 206 | Atelectasis | FAERS: 2 | US FAERS | |
| 207 | Back disorder | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 208 | Blindness | FAERS: 2 | US FAERS | |
| 209 | Blood alkaline phosphatase increased | FAERS: 2 | US FAERS | |
| 210 | Blood cholesterol increased | FAERS: 2 | US FAERS | |
| 211 | Blood iron decreased | FAERS: 2 | US FAERS | |
| 212 | Blood potassium abnormal | FAERS: 2 | US FAERS | |
| 213 | Bone pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 214 | Bronchiectasis | FAERS: 2 | US FAERS | |
| 215 | Bronchopulmonary Aspergillosis | FAERS: 2 | US FAERS | |
| 216 | Bursitis | FAERS: 2 | US FAERS | |
| 217 | Cachexia | FAERS: 2 | US FAERS | |
| 218 | Campylobacter infection | FAERS: 2 | US FAERS | |
| 219 | Catheter placement | FAERS: 2 | US FAERS | |
| 220 | Central nervous system lesion | FAERS: 2 | US FAERS | |
| 221 | Cerebral disorder | FAERS: 2 | US FAERS | |
| 222 | Chronic sinusitis | FAERS: 2 | US FAERS | |
| 223 | Cytomegalovirus test positive | FAERS: 2 | US FAERS | |
| 224 | Deafness | FAERS: 2 | US FAERS | |
| 225 | Discomfort | FAERS: 2 | US FAERS | |
| 226 | Dysarthria | FAERS: 2 | US FAERS | |
| 227 | Ejection Fraction Decreased | FAERS: 2 | US FAERS | |
| 228 | Erythema Multiforme | FAERS: 2 | US FAERS | |
| 229 | Exfoliative rash | FAERS: 2 | US FAERS | |
| 230 | Eye irritation | FAERS: 2 | US FAERS | |
| 231 | Fluid overload | FAERS: 2 | US FAERS | |
| 232 | Food Poisoning | FAERS: 2 | US FAERS | |
| 233 | Gait inability | FAERS: 2 | US FAERS | |
| 234 | Gastritis | FAERS: 2 | US FAERS | |
| 235 | Gastroenteritis | FAERS: 2 | US FAERS | |
| 236 | Gastrointestinal sounds abnormal | FAERS: 2 | US FAERS | |
| 237 | Gastrointestinal toxicity | FAERS: 2 | US FAERS | |
| 238 | General physical condition abnormal | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 239 | Hepatitis B | FAERS: 2 | US FAERS | |
| 240 | Hepatitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 241 | Hepatomegaly | FAERS: 2 | US FAERS | |
| 242 | Hydronephrosis | FAERS: 2 | US FAERS | |
| 243 | Hypersomnia | FAERS: 2 | US FAERS | |
| 244 | Hypertransaminasaemia | FAERS: 2 | US FAERS | |
| 245 | Impaired driving ability | FAERS: 2 | US FAERS | |
| 246 | Increased tendency to bruise | FAERS: 2 | US FAERS | |
| 247 | Increased upper airway secretion | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 248 | Laceration | FAERS: 2 | US FAERS | |
| 249 | Laryngitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 250 | Leukocytosis | FAERS: 2 | US FAERS | |
| 251 | Limb injury | FAERS: 2 | US FAERS | |
| 252 | Lip and/or oral cavity cancer | FAERS: 2 | US FAERS | |
| 253 | Lipase increased | FAERS: 2 | US FAERS | |
| 254 | Listeriosis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 255 | Lower respiratory tract congestion | FAERS: 2 | US FAERS | |
| 256 | Lung consolidation | FAERS: 2 | US FAERS | |
| 257 | Lymphocyte count increased | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 258 | Malnutrition | FAERS: 2 | US FAERS | |
| 259 | Metastatic Neoplasm | FAERS: 2 | US FAERS | |
| 260 | Mucocutaneous rash | FAERS: 2 | US FAERS | |
| 261 | Musculoskeletal Pain | FAERS: 2 | US FAERS | |
| 262 | Nervousness | FAERS: 2 | US FAERS | |
| 263 | No adverse event | FAERS: 2 | US FAERS | |
| 264 | Non-cardiac chest pain | FAERS: 2 | US FAERS | |
| 265 | Oral candidiasis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 266 | Pain of skin | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 267 | Paranasal sinus hypersecretion | FAERS: 2 | US FAERS | |
| 268 | Performance status decreased | FAERS: 2 | US FAERS | |
| 269 | Pertussis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 270 | Pneumococcal sepsis | FAERS: 2 | US FAERS | |
| 271 | Post procedural complication | FAERS: 2 | US FAERS | |
| 272 | Product use in unapproved indication | FAERS: 2 | US FAERS | |
| 273 | Pyelonephritis | FAERS: 2 | US FAERS | |
| 274 | Renal mass | FAERS: 2 | US FAERS | |
| 275 | Retching | FAERS: 2 | US FAERS | |
| 276 | Rheumatoid Arthritis | FAERS: 2 | US FAERS | |
| 277 | Sinus operation | FAERS: 2 | US FAERS | |
| 278 | Skin Ulcer | FAERS: 2 | US FAERS | |
| 279 | Skin necrosis | FAERS: 2 | US FAERS | |
| 280 | Skin toxicity | FAERS: 2 | US FAERS | |
| 281 | Splenectomy | FAERS: 2 | US FAERS | |
| 282 | Sudden onset of sleep | FAERS: 2 | US FAERS | |
| 283 | Suicide attempt | FAERS: 2 | US FAERS | |
| 284 | Tooth Infection | FAERS: 2 | US FAERS | |
| 285 | Unresponsive to stimuli | FAERS: 2 | US FAERS | |
| 286 | Ureteral stent insertion | FAERS: 2 | US FAERS | |
| 287 | Urinary Retention | FAERS: 2 | US FAERS | |
| 288 | Uterine Cancer | FAERS: 2 | US FAERS | |
| 289 | Viral upper respiratory tract infection | FAERS: 2 | US FAERS | |
| 290 | Wound Infection | FAERS: 2 | US FAERS | |
| 291 | Abdominal Abscess | FAERS: 1 | US FAERS | |
| 292 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 293 | Actinic keratosis | FAERS: 1 | US FAERS | |
| 294 | Activities of daily living impaired | FAERS: 1 | US FAERS | |
| 295 | Acute graft versus host disease in intestine | FAERS: 1 | US FAERS | |
| 296 | Agitation | FAERS: 1 | US FAERS | |
| 297 | Alcohol abuse | FAERS: 1 | US FAERS | |
| 298 | Alcohol poisoning | FAERS: 1 | US FAERS | |
| 299 | Allergic respiratory symptom | FAERS: 1 | US FAERS | |
| 300 | Amylase increased | FAERS: 1 | US FAERS | |
| 301 | Anal abscess | FAERS: 1 | US FAERS | |
| 302 | Aortic Aneurysm | FAERS: 1 | US FAERS | |
| 303 | Apathy | FAERS: 1 | US FAERS | |
| 304 | Aphagia | FAERS: 1 | US FAERS | |
| 305 | Apoptosis | FAERS: 1 | US FAERS | |
| 306 | Appendicitis | FAERS: 1 | US FAERS | |
| 307 | Arthropathy | FAERS: 1 | US FAERS | |
| 308 | Arthropod sting | FAERS: 1 | US FAERS | |
| 309 | Autologous bone marrow transplantation therapy | FAERS: 1 | US FAERS | |
| 310 | B-cell lymphoma refractory | FAERS: 1 | US FAERS | |
| 311 | Babesiosis | FAERS: 1 | US FAERS | |
| 312 | Bacteriuria | FAERS: 1 | US FAERS | |
| 313 | Biliary sepsis | FAERS: 1 | US FAERS | |
| 314 | Biopsy liver abnormal | FAERS: 1 | US FAERS | |
| 315 | Biopsy | FAERS: 1 | US FAERS | |
| 316 | Bladder Neoplasm | FAERS: 1 | US FAERS | |
| 317 | Blood creatine increased | FAERS: 1 | US FAERS | |
| 318 | Blood electrolytes abnormal | FAERS: 1 | US FAERS | |
| 319 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 320 | Blood triglycerides increased | FAERS: 1 | US FAERS | |
| 321 | Blood uric acid abnormal | FAERS: 1 | US FAERS | |
| 322 | Bowel movement irregularity | FAERS: 1 | US FAERS | |
| 323 | Bronchopneumopathy | FAERS: 1 | US FAERS | |
| 324 | Burning sensation | FAERS: 1 | US FAERS | |
| 325 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 326 | Cardiac infection | FAERS: 1 | US FAERS | |
| 327 | Cardiomegaly | FAERS: 1 | US FAERS | |
| 328 | Cardiotoxicity | FAERS: 1 | US FAERS | |
| 329 | Carotid artery occlusion | FAERS: 1 | US FAERS | |
| 330 | Carpal Tunnel Syndrome | FAERS: 1 | US FAERS | |
| 331 | Central venous catheter removal | FAERS: 1 | US FAERS | |
| 332 | Cholecystitis infective | FAERS: 1 | US FAERS | |
| 333 | Cholecystitis | FAERS: 1 | US FAERS | |
| 334 | Cholelithiasis | FAERS: 1 | US FAERS | |
| 335 | Clostridium test positive | FAERS: 1 | US FAERS | |
| 336 | Completed Suicide | FAERS: 1 | US FAERS | |
| 337 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 338 | Cystitis escherichia | FAERS: 1 | US FAERS | |
| 339 | Cyst | FAERS: 1 | US FAERS | |
| 340 | Dacryocanaliculitis | FAERS: 1 | US FAERS | |
| 341 | Delirium | FAERS: 1 | US FAERS | |
| 342 | Depressed mood | FAERS: 1 | US FAERS | |
| 343 | Dermatitis | FAERS: 1 | US FAERS | |
| 344 | Diabetes mellitus inadequate control | FAERS: 1 | US FAERS | |
| 345 | Drain site complication | FAERS: 1 | US FAERS | |
| 346 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 347 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 348 | Drug resistance | FAERS: 1 | US FAERS | |
| 349 | Drug withdrawal syndrome | FAERS: 1 | US FAERS | |
| 350 | Dysentery | FAERS: 1 | US FAERS | |
| 351 | Dysuria | FAERS: 1 | US FAERS | |
| 352 | Electrocardiogram abnormal | FAERS: 1 | US FAERS | |
| 353 | Electrolyte depletion | FAERS: 1 | US FAERS | |
| 354 | Empyema | FAERS: 1 | US FAERS | |
| 355 | Enterococcal infection | FAERS: 1 | US FAERS | |
| 356 | Enterocolitis | FAERS: 1 | US FAERS | |
| 357 | Enzyme level increased | FAERS: 1 | US FAERS | |
| 358 | Eosinophilia | FAERS: 1 | US FAERS | |
| 359 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 360 | Erysipelas | FAERS: 1 | US FAERS | |
| 361 | Escherichia sepsis | FAERS: 1 | US FAERS | |
| 362 | Excoriation | FAERS: 1 | US FAERS | |
| 363 | Extranodal marginal zone B-cell lymphoma (MALT type) recurrent | FAERS: 1 | US FAERS | |
| 364 | Eye Infection | FAERS: 1 | US FAERS | |
| 365 | Eye inflammation | FAERS: 1 | US FAERS | |
| 366 | Facial Pain | FAERS: 1 | US FAERS | |
| 367 | Facial paralysis | FAERS: 1 | US FAERS | |
| 368 | Feeling Cold | FAERS: 1 | US FAERS | |
| 369 | Feeling jittery | FAERS: 1 | US FAERS | |
| 370 | Feeling of body temperature change | FAERS: 1 | US FAERS | |
| 371 | Flank Pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 372 | Flushing | FAERS: 1 | US FAERS | |
| 373 | Food Allergy | FAERS: 1 | US FAERS | |
| 374 | Fracture pain | FAERS: 1 | US FAERS | |
| 375 | Fracture | FAERS: 1 | US FAERS | |
| 376 | Gamma-Glutamyltransferase Increased | FAERS: 1 | US FAERS | |
| 377 | Gangrene | FAERS: 1 | US FAERS | |
| 378 | Gastric ulcer | FAERS: 1 | US FAERS | |
| 379 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 380 | Gastrointestinal infection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 381 | Gastrointestinal motility disorder | FAERS: 1 | US FAERS | |
| 382 | Gastrointestinal mucosal disorder | FAERS: 1 | US FAERS | |
| 383 | Gastrointestinal obstruction | FAERS: 1 | US FAERS | |
| 384 | Giardiasis | FAERS: 1 | US FAERS | |
| 385 | Gingival erythema | FAERS: 1 | US FAERS | |
| 386 | Glaucoma | FAERS: 1 | US FAERS | |
| 387 | Groin infection | FAERS: 1 | US FAERS | |
| 388 | Guillain-Barre Syndrome | FAERS: 1 | US FAERS | |
| 389 | Hepatitis C | FAERS: 1 | US FAERS | |
| 390 | Hyperleukocytosis | FAERS: 1 | US FAERS | |
| 391 | Hypothyroidism | FAERS: 1 | US FAERS | |
| 392 | Ileus | FAERS: 1 | US FAERS | |
| 393 | Immobile | FAERS: 1 | US FAERS | |
| 394 | Immune thrombocytopenic purpura | FAERS: 1 | US FAERS | |
| 395 | Implantable defibrillator insertion | FAERS: 1 | US FAERS | |
| 396 | Inability to afford medication | FAERS: 1 | US FAERS | |
| 397 | Incarcerated hernia | FAERS: 1 | US FAERS | |
| 398 | Incarcerated inguinal hernia | FAERS: 1 | US FAERS | |
| 399 | Incontinence | FAERS: 1 | US FAERS | |
| 400 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 401 | Incorrect route of product administration | FAERS: 1 | US FAERS | |
| 402 | Inguinal mass | FAERS: 1 | US FAERS | |
| 403 | Initial insomnia | FAERS: 1 | US FAERS | |
| 404 | Intensive care unit acquired weakness | FAERS: 1 | US FAERS | |
| 405 | Intestinal adenocarcinoma | FAERS: 1 | US FAERS | |
| 406 | Irregular breathing | FAERS: 1 | US FAERS | |
| 407 | Joint injury | FAERS: 1 | US FAERS | |
| 408 | Large intestine perforation | FAERS: 1 | US FAERS | |
| 409 | Lesion excision | FAERS: 1 | US FAERS | |
| 410 | Lethargy | FAERS: 1 | US FAERS | |
| 411 | Limb operation | FAERS: 1 | US FAERS | |
| 412 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 413 | Lower respiratory tract infection bacterial | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 414 | Lower respiratory tract infection fungal | FAERS: 1 | US FAERS | |
| 415 | Lung cyst | FAERS: 1 | US FAERS | |
| 416 | Lymphadenitis viral | FAERS: 1 | US FAERS | |
| 417 | Lymphadenitis | FAERS: 1 | US FAERS | |
| 418 | Lymphocyte adoptive therapy | FAERS: 1 | US FAERS | |
| 419 | Lymphopenia | FAERS: 1 | US FAERS | |
| 420 | Malabsorption | FAERS: 1 | US FAERS | |
| 421 | Malignant transformation | FAERS: 1 | US FAERS | |
| 422 | Mantle cell lymphoma recurrent | FAERS: 1 | US FAERS | |
| 423 | Mechanical ventilation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 424 | Medical device site joint infection | FAERS: 1 | US FAERS | |
| 425 | Medication Error | FAERS: 1 | US FAERS | |
| 426 | Meniscus injury | FAERS: 1 | US FAERS | |
| 427 | Meniscus operation | FAERS: 1 | US FAERS | |
| 428 | Mental impairment | FAERS: 1 | US FAERS | |
| 429 | Metabolic acidosis | FAERS: 1 | US FAERS | |
| 430 | Metamorphopsia | FAERS: 1 | US FAERS | |
| 431 | Metastasis | FAERS: 1 | US FAERS | |
| 432 | Muscle strain | FAERS: 1 | US FAERS | |
| 433 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 434 | Myelofibrosis | FAERS: 1 | US FAERS | |
| 435 | Narcolepsy | FAERS: 1 | US FAERS | |
| 436 | Neutrophil count abnormal | FAERS: 1 | US FAERS | |
| 437 | Nocturia | FAERS: 1 | US FAERS | |
| 438 | Noninfective encephalitis | FAERS: 1 | US FAERS | |
| 439 | Noninfective gingivitis | FAERS: 1 | US FAERS | |
| 440 | Obstruction | FAERS: 1 | US FAERS | |
| 441 | Onychoclasis | FAERS: 1 | US FAERS | |
| 442 | Oral infection | FAERS: 1 | US FAERS | |
| 443 | Oropharyngeal discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 444 | Osteofibroma | FAERS: 1 | US FAERS | |
| 445 | Overdose | FAERS: 1 | US FAERS | |
| 446 | Overweight | FAERS: 1 | US FAERS | |
| 447 | Oxygen Consumption | FAERS: 1 | US FAERS | |
| 448 | Oxygen consumption increased | FAERS: 1 | US FAERS | |
| 449 | Palpitations | FAERS: 1 | US FAERS | |
| 450 | Pancreatic enlargement | FAERS: 1 | US FAERS | |
| 451 | Pancreatic toxicity | FAERS: 1 | US FAERS | |
| 452 | Partial lung resection | FAERS: 1 | US FAERS | |
| 453 | Pelvic abscess | FAERS: 1 | US FAERS | |
| 454 | Pelvic mass | FAERS: 1 | US FAERS | |
| 455 | Pemphigus | FAERS: 1 | US FAERS | |
| 456 | Penile erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 457 | Penile swelling | FAERS: 1 | US FAERS | |
| 458 | Peptostreptococcus infection | FAERS: 1 | US FAERS | |
| 459 | Peritonitis | FAERS: 1 | US FAERS | |
| 460 | Pharyngitis bacterial | FAERS: 1 | US FAERS | |
| 461 | Photophobia | FAERS: 1 | US FAERS | |
| 462 | Physical disability | FAERS: 1 | US FAERS | |
| 463 | Piloerection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 464 | Platelet Transfusion | FAERS: 1 | US FAERS | |
| 465 | Platelet count abnormal | FAERS: 1 | US FAERS | |
| 466 | Polymyalgia Rheumatica | FAERS: 1 | US FAERS | |
| 467 | Polyneuropathy | FAERS: 1 | US FAERS | |
| 468 | Positron emission tomogram abnormal | FAERS: 1 | US FAERS | |
| 469 | Posterior reversible encephalopathy syndrome | FAERS: 1 | US FAERS | |
| 470 | Procedural complication | FAERS: 1 | US FAERS | |
| 471 | Product administration interrupted | FAERS: 1 | US FAERS | |
| 472 | Product use complaint | FAERS: 1 | US FAERS | |
| 473 | Protein-losing gastroenteropathy | FAERS: 1 | US FAERS | |
| 474 | Proteinuria | FAERS: 1 | US FAERS | |
| 475 | Pseudomonal sepsis | FAERS: 1 | US FAERS | |
| 476 | Pseudomonas test positive | FAERS: 1 | US FAERS | |
| 477 | Pulmonary sepsis | FAERS: 1 | US FAERS | |
| 478 | Pulmonary toxicity | FAERS: 1 | US FAERS | |
| 479 | Radiation skin injury | FAERS: 1 | US FAERS | |
| 480 | Rales | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 481 | Remission not achieved | FAERS: 1 | US FAERS | |
| 482 | Renal artery stent placement | FAERS: 1 | US FAERS | |
| 483 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 484 | Rhonchi | FAERS: 1 | US FAERS | |
| 485 | Rotator cuff syndrome | FAERS: 1 | US FAERS | |
| 486 | Salivary gland pain | FAERS: 1 | US FAERS | |
| 487 | Sarcoma | FAERS: 1 | US FAERS | |
| 488 | Scab | FAERS: 1 | US FAERS | |
| 489 | Sciatica | FAERS: 1 | US FAERS | |
| 490 | Skin discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 491 | Skin laceration | FAERS: 1 | US FAERS | |
| 492 | Sluggishness | FAERS: 1 | US FAERS | |
| 493 | Spinal column stenosis | FAERS: 1 | US FAERS | |
| 494 | Splenic Rupture | FAERS: 1 | US FAERS | |
| 495 | Sudden death | FAERS: 1 | US FAERS | |
| 496 | Systemic Inflammatory Response Syndrome | FAERS: 1 | US FAERS | |
| 497 | Tachycardia | FAERS: 1 | US FAERS | |
| 498 | Temperature intolerance | FAERS: 1 | US FAERS | |
| 499 | Therapy partial responder | FAERS: 1 | US FAERS | |
| 500 | Thermal burn | FAERS: 1 | US FAERS | |
| 501 | Thirst | FAERS: 1 | US FAERS | |
| 502 | Thoracic cavity drainage | FAERS: 1 | US FAERS | |
| 503 | Thoracostomy | FAERS: 1 | US FAERS | |
| 504 | Thrombosis in device | FAERS: 1 | US FAERS | |
| 505 | Tongue discomfort | FAERS: 1 | US FAERS | |
| 506 | Tooth Extraction | FAERS: 1 | US FAERS | |
| 507 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 508 | Tumour haemorrhage | FAERS: 1 | US FAERS | |
| 509 | Underweight | FAERS: 1 | US FAERS | |
| 510 | Urinary hesitation | FAERS: 1 | US FAERS | |
| 511 | Urine output increased | FAERS: 1 | US FAERS | |
| 512 | Ventricular Fibrillation | FAERS: 1 | US FAERS | |
| 513 | Vertigo | FAERS: 1 | US FAERS | |
| 514 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 515 | cancer surgery | FAERS: 1 | US FAERS | |
| 516 | nervous system disorder | FAERS: 1 | US FAERS | |
| 517 | pseudomembranous colitis | FAERS: 1 | US FAERS | |
| 518 | skin abrasion | FAERS: 1 | US FAERS | |
| 519 | Lymphocyte count decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 520 | Therapeutic product effect decreased | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.